Sort
15,273 grants matching “antimicrobial resistance”
Role of inflammation, innate resistance, and immunity in carcinogenesis
$741,872Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Pre-clinical Safety and Toxicology Studies of a PO-administered b-lactam-tarocin combination agent to treat methicillin susceptible and resistant staphylococci
$741,804Terry Roemer · Hackensack University Medical Center · U19 · FY2025 · AI
Involvement Of Human Viruses Associated With Chronic Neurologic Disease
$741,698Steven Jacobson · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
Molecular mapping of microbial communities at the host-pathogen interface by multi-modal 3-dimensional imaging mass spectrometry
$740,949Eric P Skaar · Vanderbilt University Medical Center · R01 · FY2025 · AI
Preclinical development of teixobactin, a new antibiotic
$740,926Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R44 · FY2016 · AI
TOPICAL PROTEGRINS TO PREVENT STDS &HIV INFECTION
$740,923University Of California Los Angeles · P01 · FY2002 · AI
Staphylococcus aureus SPREAD (S. aureus Study of Prevalence Resistance and Environmental Dissemination)
$740,872Michael Zdenek David · University Of Pennsylvania · R01 · FY2024 · AI
Immunity to Cryptosporidium
$740,740Boris Striepen · University Of Pennsylvania · R01 · FY2023 · AI
Immunity to Cryptosporidium
$740,740Boris Striepen · University Of Pennsylvania · R01 · FY2022 · AI
Immunity to Cryptosporidium
$740,740Boris Striepen · University Of Pennsylvania · R01 · FY2024 · AI
The role of enteric pathogens and antimicrobial resistance in driving clinical and nutritional deterioration, and azithromycin's potential effect, among children discharged from hospital in Kenya
$740,701Patricia Pavlinac · University Of Washington · R01 · FY2021 · AI
Broad spectrum Tricyclics GyrB, ParE inhibitors for antibacterial applications
$739,978Kenneth Bartizal · Rbhs-New Jersey Medical School · U19 · FY2015 · AI
Mechanisms of cefiderocol nonsusceptibility and resistance evolution in carbapenem-resistant pathogens
$739,974En Huang · Ohio State University · R01 · FY2025 · AI
Multiscale modeling of the battle over iron in invasive lung infection
$739,948Reinhard Laubenbacher · University Of Florida · R01 · FY2022 · AI
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
$739,601Christian C Melander · University Of Notre Dame · R01 · FY2023 · AI
Developmental and Translational Pharmacology of Pediatric Antimicrobial Therapy
$739,569Edmund Vincent Capparelli · University Of California, San Diego · U54 · FY2012 · HD
Pain drugs based on nicotinic receptor subtype antagonists
$739,558Kelvin W Gee · University Of California-Irvine · R01 · FY2019 · DA
Small molecules for perturbing iron homeostasis in bacterial biofilms
$739,544Mario Rivera · Louisiana State Univ A&M Col Baton Rouge · R01 · FY2025 · AI
Changing Cultures in Sepsis: Rapid single-cell pathogen identification and antibiotic susceptibility testing directly from whole blood
$739,520Samuel Yang · Stanford University · R01 · FY2021 · AI
Functional Genomics Core
$739,509Anthony Haag · University Of Texas Hlth Sci Ctr Houston · P01 · FY2020 · AI
Immunity to Cryptosporidium
$739,410Boris Striepen · University Of Pennsylvania · R01 · FY2021 · AI
Staphylococcus aureus SPREAD (S. aureus Study of Prevalence Resistance and Environmental Dissemination)
$739,156Michael Zdenek David · University Of Pennsylvania · R01 · FY2023 · AI
Experimental human infection with isogenic mutants of Neisseria gonorrhoeae
$739,134Marcia Metzgar Hobbs · Univ Of North Carolina Chapel Hill · U01 · FY2018 · AI
Exploration, conservation, & development of marine biodiversity in Fiji
$738,771Mark E Hay · Georgia Institute Of Technology · U01 · FY2011 · TW
Structure/Function of Transcription Complex Regulation
$738,742Robert Landick · University Of Wisconsin-Madison · R01 · FY2018 · GM